Grail, a company that aims to use a blood test to spot cancer, has announced a massive round of funding for its experimental approach. A billion dollars sounds like a lot of money. But when your ambitions are as big as the...

This story from GE Reports was originally published during RSNA last year to help promote their new mammography equipment and referenced the good work being done at Gustave Roussy Cancer Center in a southern suburb of Paris.  But same day...

One of the best parts of this job, being a news gatherer and news distributor for all of you is getting to know about several great companies and the dedicated people who make them go. One of those companies is Indica Labs based in New...

  In 2010, results of a phase 3 randomized controlled trial showed that targeted therapy directed against HER2 statistically significantly prolonged overall survival compared with chemotherapy alone in patients with HER2–positive...

I received a lot of feedback offline about Part 1 of this post (see: “To Sign Out or Not to Sign Out? Part 1” ) from a number of pathologists echoing my sentiments on the issue of turnaround time in general and needs/expectations from...

Tuesday, January 24th 2017 4.00 PM – 5.00 PM GMT Since the development of modern anatomical pathology as a medical discipline in the 19th Century it has been uniquely bound to the location of the specimen, requiring direct (microscopic)...